Patent Yard Sign in
Canadian application, no grantCanada

Novel asymmetric synthesis of r-.alpha.-propyl-piperonyl amine and its analogs

CA 2249401 A1 · Owner: The Dupont Merck Pharmaceutical Company · Inventors: Anzalone, Luigi; Waltermire, Robert Eugene; Li, Hui-Yin

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Processes for the preparation of R-.alpha.-propyl-piperonyl amine and its analogs, such compounds being useful intermediates in the preparation of elastase inhibitors, and intermediates useful for making R-.alpha.-propylpiperonyl amine are described.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 17, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 17, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 17, 1997
GrantedNo grant recorded
Term endedMarch 17, 2017
Patent numberCA 2249401 A1
Classification (IPC)C07D317/58

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedMarch 17, 1997Term endedMarch 17, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.